The Role of Gut Microbiota and Use of Probiotics in the Treatment of Upper Gastrointestinal Diseases
The Korean Journal of Helicobacter and Upper Gastrointestinal Research
; : 99-105, 2019.
Article
de Ko
| WPRIM
| ID: wpr-761578
Bibliothèque responsable:
WPRO
ABSTRACT
Gut microbiota have been known to play an essential role in host immunity and metabolism. Dysbiosis is associated with various gastrointestinal (GI) and other diseases such as cancers, metabolic diseases, allergies, and immunological disorders. So far, the role of gut microbiota has been studied mainly in lower GI disease but has recently been reported in upper GI diseases other than Helicobacter pylori infection, including Barrett's esophagus, esophageal carcinoma, gastric cancer, functional dyspepsia, and non-steroidal anti-inflammatory drug-induced small intestinal mucosal injury. Probiotics have some beneficial effect on these diseases, but the effects are strain specific.
Mots clés
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Tumeurs de l'estomac
/
Oesophage de Barrett
/
Anti-inflammatoires non stéroïdiens
/
Helicobacter pylori
/
Infections à Helicobacter
/
Probiotiques
/
Tube digestif supérieur
/
Dyspepsie
/
Dysbiose
/
Microbiote
langue:
Ko
Texte intégral:
The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Année:
2019
Type:
Article